Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 3

Quality Control of the Qualitative Real Time PCR Method for the Detection of Aspergillus DNA in Clinical Samples

Aspergillus DNA’sının Klinik Örneklerde Gösterilmesine Yönelik Geliştirilen Kalitatif Gerçek Zamanlı PCR Yönteminin Kalite Kontrolü

Pages
108–115
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinical studies with large number of samples should be initiated to integrate PCR in the diagnostic armentarium of aspergillosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The culture of clinical samples is positive in only 50% of the aspergillosis cases.
📊
Key Findings & Data:In most neutropenic fever patients, antifungal treatment is generally commenced based on empirical considerations and reduces the growth rates in microbiological cultures.
💡
Conclusion & Impact:Clinical studies with large number of samples should be initiated to integrate PCR in the diagnostic armentarium of aspergillosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The culture of clinical samples is positive in only 50% of the aspergillosis cases. In most neutropenic fever patients, antifungal treatment is generally commenced based on empirical considerations and reduces the growth rates in microbiological cultures. Polymerase chain reaction (PCR) screening for circulating DNA is not related to treatment in order for the DNA to be detected under antifungal effect. We evaluated the utility of qualitative real time PCR assay for the detection of Aspergillus DNA. Materials and Methods: DNA isolation was performed without a commercial system. The presence of DNA from the samples was detected using TaqMan PCR targeting fungal 28S rDNA gene. Diagnostic approach of the assay was evaluated by using different samples. Sixty samples including blood samples contaminated with Aspergillus conidia, colony suspensions, tissue and blood samples of experimentally infected animals, and patient samples obtained from suspected cases were subjected to testing. Results: False negative results were obtained from tissue samples of experimentally infected animals. When the results were analysed, 4 (40%) of the tissue samples, 3 (30%) of the blood samples, 2 (20%) of the simulated blood samples, and 1 (10%) of the patient samples failed to achieve the same level of detection. Colony suspensions were found to be all positive (100%). Conclusion: The efficiency of the Aspergillus PCR is limited in tissue samples, but sufficient in blood samples, and should be qualified to exclude false negativity. Clinical studies with large number of samples should be initiated to integrate PCR in the diagnostic armentarium of aspergillosis.

Özet

Giriş: Aspergillus cinsi küf mantarlarının klinik örneklerde kültürde üretilme başarısı %50’yi geçmemektedir. Nötropenik ateş dönemindeki hastaların bir çoğunda ampirik antifungal tedavi başlanması nedeniyle, kültürde herhangi bir mantarın üretilebilme olasılığı azalmaktadır. Moleküler yöntemlerde hedeflenen mikroorganizmanın DNA’sı gösterildiği için tedavi başlanmış olması tanıyı olumsuz yönde etkilememektedir. Bu çalışmada, Aspergillus cinsi mantarların DNA’sının gösterilmesi için geliştirilen kalitatif gerçek zamanlı polimeraz zincir reaksiyonu yöntemi sunulmuştur. Materyal ve Metod: Örneklerden DNA izolasyonu hazır sistem kullanılmadan yapılmıştır. Aspergillus cinsi mantarların rDNA gen bölgesinden 28S alt ünitesi hedeflenmiş, TaqMan amplifikasyon gerçekleştirilmiştir. Yöntemin aspergillozdaki tanısal değeri farklı örnekler kullanılarak incelenmiştir. Aspergillus kolonisi ile kontamine edilen “simüle” kan örnekleri, aspergilloz oluşturulan deney hayvanı kan ve dokuları ve aspergilloz şüphesiyle takip edilen hasta örnekleri ile toplam 60 örnek çalışılmıştır. Bulgular: En çok yalancı negatiflik deneysel olarak aspergilloz oluşturulmuş hayvanların doku örneklerinde elde edilmiştir. Hayvan doku örneklerinin 4 (%40)’ünde, hayvan kan örneklerinin 3 (%30)’ünde, simüle kan örneklerinin 2 (%20)’sinde, hasta örneklerinin 1 (%10)’inde yalancı negatif sonuç alınmıştır. Koloni süspansiyonlarının tamamı pozitif bulunmuştur. Sonuç: Geliştirdiğimiz yöntemin kan örneklerinde Aspergillus DNA’sının gösterilmesinde başarılı olduğu ancak, doku örnekleri için geliştirilmesi gerektiğine karar verilmiştir. Yöntemin tanısal değerinin geniş gruplarda yapılacak çalışmalar ile desteklenmesi gerekmektedir.

🔖

Cite This Article

ARSLAN, S. Ö., AYDIN, M., JABBAN, I. I. K., SEYER, A., FOUAD, A. A., YALÇIN, B., DEMİR, F., BİTER, G., KALKANCI, A., KUŞTİMUR, S. (2018). Quality Control of the Qualitative Real Time PCR Method for the Detection of Aspergillus DNA in Clinical Samples. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 3, 108–115. https://ajindex.com/articles/189692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Badiee P, Alborzi A. Detection of Aspergillus species in bone marrow transplant patients. J Infect Dev Ctries 2010;4:511-6.
  2. Buchheidt D, Hummel M. Aspergillus polymerase chain reaction (PCR) diagnosis. Med Mycol 2005;43(Suppl I);- SI39-S45. Abdin MZ, Ahmad MM, Javed S. Advances in molecular detection of Aspergillus: an uptake. Arch Microbiol 2010;192:409-25. Bretagne S. Primary diagnostic approaches of invasive aspergillosis-molecular testing. Med Mycol 2011;49(Suppl I):S48-S53. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al.; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
  3. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al.; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
  4. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, et al.; European Aspergillus PCR Initiative. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010;48:1231-40.
  5. Schulz B, Weber K, Radecke C, Scheer C, Ruhnke M. Effect of different sample volumes on DNA extraction of Aspergillus fumigatus from whole blood. Clin Microbiol Infect 2009;15:686-8.
  6. Loeffler J, Barnes R, Donnelly JP. Standardization of Aspergillus PCR diagnosis. Bone Marrow Transplant 2012;47:299- 300. Blennow O, Mattsson J. Standardization of Aspergillus PCR is needed. Bone Marrow Transplant 2011;46:1018. Gomez-Lopez A, Martin-Gomez MT, Martin-Davila P, Lopez-Onrubia P, Gavalda J, Fortun J, et al.; Spanish Research Network of Infection in Transplantation (RESITRA).Detection of fungal DNA by real-time polymerase chain reaction: evaluation of 2 methodologies in experimental pulmonary aspergillosis. Diagn Microbiol Infect Dis 2006;56:387-93.
  7. Aydoğan S, Kuşt